Year: 2021

Australian-Iranian Spikogen vaccine has been approved for emergency use in IranAustralian-Iranian Spikogen vaccine has been approved for emergency use in Iran

0 Comment

Spikogen vaccine is the result of a collaboration between Vaxine and CinnaGen, a private company with operations in the Middle East. The Iranian Food and Drug Administration (IFDA) has issued an emergency use authorisation for Spikogen vaccine. Plans are being made by the partners to expand approval to other countries. https://en.mehrnews.com/news/179432/Iran-issues-emergency-permit-for-new-local-Covid-19-vaccine

Recent paper on use of our Advax-CpG adjuvant in Herpes Simplex virus Vaccine developmentRecent paper on use of our Advax-CpG adjuvant in Herpes Simplex virus Vaccine development

0 Comment

This latest paper highlights a Herpes simplex virus vaccine being developed in collaboration with our Swedish partners. The Advax-CpG adjuvant in this herpes simplex vaccine is the same approach as we are using in our current COVID-19 vaccine. Link to the paper:https://www.sciencedirect.com/science/article/pii/S0264410X21010987

CinnaGen Initiates a Phase 3 Clinical Trial of Vaxine’s COVID-19 Vaccine TechnologyCinnaGen Initiates a Phase 3 Clinical Trial of Vaxine’s COVID-19 Vaccine Technology

0 Comment

  On August 07, 2021, the first volunteer enrolled in the Phase 3 clinical study of Cinnagen’s COVID-19 vaccine candidate in Iran. The study is a randomized, double-blind, placebo-controlled trial and will evaluate the efficacy and safety of the vaccine in 16,876 adult participants. Subjects receive two doses, 21 days apart, of either Spikogen vaccine or […]

Australian-made coronavirus vaccine COVAX-19 shows promise in clinical trialsAustralian-made coronavirus vaccine COVAX-19 shows promise in clinical trials

0 Comment

Vaxine’s COVID-19 vaccine technology has progressed to the final stages of a human clinical trial, after strong preliminary results demonstrating its ability to prevent coronavirus infections in animal models. This highly effective protein-based vaccine can be manufactured on a large scale and remain stable in normal refrigerated conditions. Read this full article here:Australian-made coronavirus vaccine […]

Promising clinical trial of Vaxine’s Covid-19 vaccine technologyPromising clinical trial of Vaxine’s Covid-19 vaccine technology

0 Comment

CinnaGen Co. announced that the results of preliminary analysis of data from the ongoing Phase 2 human clinical trial of spikogen vaccine based on Vaxine’s COVID-19 vaccine technology were positive. This vaccine comprises a recombinant spike protein antigen formulated with the proprietary Advax-SM adjuvant. The Phase 2 study was a randomized, double-blind, placebo-controlled trial conducted on […]